LSZ 150 mcg Blotters (Lysergic Acid Derivative) – Scientific Product Description

Giriş

LSZ (Lysergic Acid 2,4-dimethylazetidide) is a semi-synthetic lysergamide, structurally related to LSD. These 150 mcg blotters were developed for use in strictly controlled laboratory environments and are intended for research into the pharmacological properties . psychedelic compounds. Production takes place under strict quality control.

Technical Specifications

• Active ingredient: LSZ (Lysergic Acid 2,4-dimethylazetidide)
• Dosage per blotter: 150 ± 5 mcg
• Blotter size: 5×5 mm, perforated squares
• Carrier medium: High-quality chromatography paper
• Purity: ≥98% (HPLC analyzed)
• Shelf life: 24 months when stored between 2–8°C in a light-proof container.

Araştırma uygulamaları

LSZ blotters are used in:

• Receptor binding studies targeting 5-HT2A agonism
• Comparative pharmacological analysis within the lysergamide class
• Dose-response studies in controlled models
• Metabolic stability studies in vitro

Quality control

Each batch is subjected to:

• HPLC-UV quantification of active substance
• Confirmation via mass spectrometry
• Dosage uniformity analysis
• Microbiological control of the carrier material

Güvenlik protokolü

Handling

• Use nitrile gloves for all handling
• Avoid direct contact with skin
• Work only in a controlled laboratory environment
• Wear protective clothing, goggles and, if necessary, respiratory protection

Storage

• Temperature: 2–8°C
• Protection from light and moisture is required
• Use only the original, sealed packaging

Regulatory Framework

• Classified under the Dutch Opium Act (Schedule I)
• Only permitted for licensed research institutions
• Not suitable for human consumption
• Export and distribution subject to regulations

Order information

• Packaging unit: 10 blotters per sheet
• Delivery: Refrigerated transport with temperature registration
• Documentation: COA and full analytical specifications available per batch

Scientific References

• Nichols (2016) – Psychedelics as Medicines
• Brandt et al. (2020) – Lysergamide Pharmacology
• EMCDDA (2023) – Technical Report on New Psychoactive Substances

Önemli Not

This product is intended solely for legally authorized scientific research. Sale and use are restricted to qualified professionals within a regulated research environment. The purchaser is solely responsible for compliance with applicable laws and regulations.

1cP-LSD 150 MCG Art Blotters O-DSMT 50mg Pelet 1V-LSD 150 MCG Blotterlar 6-CL-ADBA 2-CMC 250mg pellet